Ozempic Linked to Increased Risk of Blindness
Ozempic and Wegovy, which contain the glucagon-like peptide 1 receptor agonist (GLP-1RA) semaglutide, continue to be blockbuster drugs for Danish pharmaceutical giant Novo Nordisk. A May 2024 report from Forbes noted that the company’s overall sales doubled compared to the previous year, collecting a whopping $1.35 billion.1 While these options may seem convenient, the fixation … Read more